146 related articles for article (PubMed ID: 34154795)
1. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2021 Jun; ():. PubMed ID: 34154795
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(2):82-88. PubMed ID: 35397828
[TBL] [Abstract][Full Text] [Related]
3. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
McMurray JS; Connor N; Ford CN
Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
[TBL] [Abstract][Full Text] [Related]
4. Surgery and Adjuvant Therapy Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis.
Hock K; Kennedy A; Howell R; Friedman A; de Alarcon A; Khosla S
Laryngoscope; 2022 Dec; 132(12):2420-2426. PubMed ID: 35119691
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
8. Intralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta-analysis.
Zagzoog FH; Mogharbel AM; Alqutub A; Bukhari M; Almohizea MI
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):601-627. PubMed ID: 37831132
[TBL] [Abstract][Full Text] [Related]
9. Trends in recurrent respiratory papillomatosis treatment.
Ballestas SA; Shelly S; Soriano RM; Klein A
Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(2):109-120. PubMed ID: 32312478
[TBL] [Abstract][Full Text] [Related]
10. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
Rogers DJ; Ojha S; Maurer R; Hartnick CJ
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):496-501. PubMed ID: 23681032
[TBL] [Abstract][Full Text] [Related]
11. Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults.
Kupfer RA; Çadalli Tatar E; Barry JO; Allen CT; Merati AL
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):689-92. PubMed ID: 26908550
[TBL] [Abstract][Full Text] [Related]
12. Intralesional Cidofovir: A Systematic Review of Administration Protocols and Long-term Recurrence Rates in Adult and Juvenile Recurrent Respiratory Papillomatosis.
Pamonag MZ; Seery AM; Omari AIA; Alnouri G; Sataloff RT
J Voice; 2023 Aug; ():. PubMed ID: 37620175
[TBL] [Abstract][Full Text] [Related]
13. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
Sheahan P; Sexton S; Russell JD
J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
[TBL] [Abstract][Full Text] [Related]
14. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
Akst LM; Lee W; Discolo C; Knott D; Younes A; Koltai PJ
Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342
[TBL] [Abstract][Full Text] [Related]
15. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
17. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
18. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience.
Maturo S; Hartnick CJ
Arch Otolaryngol Head Neck Surg; 2010 Jun; 136(6):561-5. PubMed ID: 20566906
[TBL] [Abstract][Full Text] [Related]
19. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
Lee AS; Rosen CA
J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
